ATE425767T1 - Konjugate von cyanovirin-varianten und einem polyalkylenoxid - Google Patents
Konjugate von cyanovirin-varianten und einem polyalkylenoxidInfo
- Publication number
- ATE425767T1 ATE425767T1 AT03813787T AT03813787T ATE425767T1 AT E425767 T1 ATE425767 T1 AT E425767T1 AT 03813787 T AT03813787 T AT 03813787T AT 03813787 T AT03813787 T AT 03813787T AT E425767 T1 ATE425767 T1 AT E425767T1
- Authority
- AT
- Austria
- Prior art keywords
- cyanovirin
- conjugates
- variants
- polyalkylene oxide
- water
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Engineering & Computer Science (AREA)
- AIDS & HIV (AREA)
- Pulmonology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
- Polyethers (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US43595002P | 2002-12-19 | 2002-12-19 | |
| US46173103P | 2003-04-09 | 2003-04-09 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE425767T1 true ATE425767T1 (de) | 2009-04-15 |
Family
ID=32685420
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03813787T ATE425767T1 (de) | 2002-12-19 | 2003-12-18 | Konjugate von cyanovirin-varianten und einem polyalkylenoxid |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US7267941B2 (de) |
| EP (1) | EP1620129B1 (de) |
| JP (2) | JP2006517400A (de) |
| KR (1) | KR101145990B1 (de) |
| AT (1) | ATE425767T1 (de) |
| AU (1) | AU2003301122B2 (de) |
| CA (1) | CA2507904C (de) |
| DE (1) | DE60326774D1 (de) |
| MX (1) | MXPA05006688A (de) |
| WO (1) | WO2004056852A2 (de) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004056852A2 (en) * | 2002-12-19 | 2004-07-08 | Nektar Therapeutics Al, Corp. | Cyanovirin variant-polymer conjugates |
| US7432331B2 (en) * | 2002-12-31 | 2008-10-07 | Nektar Therapeutics Al, Corporation | Hydrolytically stable maleimide-terminated polymers |
| EP1930344A4 (de) * | 2005-09-29 | 2008-12-31 | Shionogi & Co | Polypeptid mit antiangiogener wirkung |
| CN101534847A (zh) | 2006-08-04 | 2009-09-16 | 普罗龙药品公司 | 修饰型促红细胞生成素 |
| ATE531385T1 (de) * | 2006-08-18 | 2011-11-15 | Us Gov Health & Human Serv | Anti-h5n1-influenza-aktivität des antiviralen proteins cyanovirin |
| JP2010503630A (ja) | 2006-09-15 | 2010-02-04 | クレアビリス・セラピューティクス・エスピーエー | ＨＭＧＢ１のＢｏｘ−ＡおよびＨＭＧＢ１のＢｏｘ−Ａ変異体のポリマー複合体 |
| CN101143894A (zh) * | 2007-06-22 | 2008-03-19 | 中国药科大学 | 高效抑制血管生成多肽及其物理化学修饰方法和应用 |
| US8557534B2 (en) | 2007-12-27 | 2013-10-15 | Baxter International Inc. | Method and compositions for specifically detecting physiologically acceptable polymer molecules |
| RU2582244C2 (ru) | 2008-06-30 | 2016-04-20 | ИЭсБиЭйТЕК, ЭН АЛЬКОН БАЙОМЕДИКАЛ РИСЕРЧ ЮНИТ ЭлЭлСи | Функционализированные полипептиды |
| KR101671537B1 (ko) | 2008-08-11 | 2016-11-01 | 넥타르 테라퓨틱스 | 다분지형 중합체 알카노에이트 컨쥬게이트 |
| PT2349342T (pt) | 2008-10-17 | 2018-10-26 | Baxalta Inc | Factores sanguíneos modificados que compreendem um baixo grau de polímero solúvel na água |
| JP5775820B2 (ja) * | 2008-10-21 | 2015-09-09 | バクスター・インターナショナル・インコーポレイテッドＢａｘｔｅｒ Ｉｎｔｅｒｎａｔｉｏｎａｌ Ｉｎｃｏｒｐ０Ｒａｔｅｄ | 遊離可能ｐｅｇ試薬を有するプロドラッグｐｅｇタンパク質結合体において活性成分（インビトロ脱ペグ化）を決定する方法 |
| US8883165B2 (en) * | 2009-08-28 | 2014-11-11 | The Chemo-Sero-Therapeutic Research Institute | Modified peptide vaccine derived from influenza M2 |
| CN101638435B (zh) * | 2009-09-04 | 2011-11-16 | 暨南大学 | 一种蓝藻病毒蛋白n突变体、其修饰衍生物及应用 |
| US10894087B2 (en) | 2010-12-22 | 2021-01-19 | Nektar Therapeutics | Multi-arm polymeric prodrug conjugates of cabazitaxel-based compounds |
| US20130331443A1 (en) | 2010-12-22 | 2013-12-12 | Nektar Therapeutics | Multi-arm polymeric prodrug conjugates of taxane-based compounds |
| WO2012166555A1 (en) | 2011-05-27 | 2012-12-06 | Nektar Therapeutics | Water - soluble polymer - linked binding moiety and drug compounds |
| JP6255348B2 (ja) * | 2011-12-19 | 2017-12-27 | ジェンザイム・コーポレーション | 甲状腺刺激ホルモン組成物 |
| WO2019108656A1 (en) | 2017-11-28 | 2019-06-06 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Microbicidal composition |
| CN111801120A (zh) | 2017-12-29 | 2020-10-20 | 豪夫迈·罗氏有限公司 | 用于提供聚乙二醇化蛋白质组合物的方法 |
| US12208142B2 (en) | 2017-12-29 | 2025-01-28 | Hoffmann-La Roche Inc. | Process for providing PEGylated protein composition |
| PL3731873T3 (pl) * | 2017-12-29 | 2022-04-25 | F. Hoffmann-La Roche Ag | Sposób dostarczania kompozycji pegylowanego białka |
| CN116854785A (zh) * | 2023-05-16 | 2023-10-10 | 青岛双元泰和药业有限公司 | 位点特异性修饰和标记的抗病毒肽氰病毒素n |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5766897A (en) | 1990-06-21 | 1998-06-16 | Incyte Pharmaceuticals, Inc. | Cysteine-pegylated proteins |
| US6780847B2 (en) * | 1995-04-27 | 2004-08-24 | The United States Of America As Represented By The Department Of Health And Human Services | Glycosylation-resistant cyanovirins and related conjugates, compositions, nucleic acids, vectors, host cells, methods of production and methods of using nonglycosylated cyanovirins |
| US20060122374A1 (en) | 2002-02-07 | 2006-06-08 | Peter Mertins | Albumin-fused anti-angiogenesis peptides |
| WO2004056852A2 (en) * | 2002-12-19 | 2004-07-08 | Nektar Therapeutics Al, Corp. | Cyanovirin variant-polymer conjugates |
-
2003
- 2003-12-18 WO PCT/US2003/040585 patent/WO2004056852A2/en not_active Ceased
- 2003-12-18 JP JP2005502650A patent/JP2006517400A/ja active Pending
- 2003-12-18 KR KR1020057011500A patent/KR101145990B1/ko not_active Expired - Lifetime
- 2003-12-18 AU AU2003301122A patent/AU2003301122B2/en not_active Expired
- 2003-12-18 MX MXPA05006688A patent/MXPA05006688A/es active IP Right Grant
- 2003-12-18 DE DE60326774T patent/DE60326774D1/de not_active Expired - Lifetime
- 2003-12-18 US US10/742,465 patent/US7267941B2/en not_active Expired - Lifetime
- 2003-12-18 EP EP03813787A patent/EP1620129B1/de not_active Expired - Lifetime
- 2003-12-18 CA CA2507904A patent/CA2507904C/en not_active Expired - Lifetime
- 2003-12-18 AT AT03813787T patent/ATE425767T1/de not_active IP Right Cessation
-
2007
- 2007-08-02 US US11/832,925 patent/US7547509B2/en not_active Expired - Lifetime
-
2010
- 2010-09-27 JP JP2010216141A patent/JP4903891B2/ja not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| KR20050084433A (ko) | 2005-08-26 |
| CA2507904A1 (en) | 2004-07-08 |
| KR101145990B1 (ko) | 2012-08-23 |
| WO2004056852A3 (en) | 2004-10-07 |
| AU2003301122A1 (en) | 2004-07-14 |
| AU2003301122B2 (en) | 2009-11-26 |
| JP2011050382A (ja) | 2011-03-17 |
| EP1620129B1 (de) | 2009-03-18 |
| MXPA05006688A (es) | 2006-02-22 |
| WO2004056852A2 (en) | 2004-07-08 |
| JP4903891B2 (ja) | 2012-03-28 |
| EP1620129A2 (de) | 2006-02-01 |
| US7267941B2 (en) | 2007-09-11 |
| US20080015151A1 (en) | 2008-01-17 |
| JP2006517400A (ja) | 2006-07-27 |
| US7547509B2 (en) | 2009-06-16 |
| CA2507904C (en) | 2014-12-02 |
| US20040258706A1 (en) | 2004-12-23 |
| DE60326774D1 (de) | 2009-04-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60326774D1 (de) | Konjugate von cyanovirin-varianten und einem polyalkylenoxid | |
| TW200631604A (en) | Ophthalmic compositions comprising polyether substituted polymers | |
| DE50306232D1 (de) | Ampholytisches copolymer und dessen verwendung | |
| ATE422880T1 (de) | Heterofunktionelle copolymere von glycerol und polyethylenglykol, ihre konjugate und zusammensetzungen | |
| MX2007005724A (es) | Articulo para tratamiento cosmetico que comprende un sustrato y una composicion en gel. | |
| DE502004010014D1 (de) | Anionische ampholytische copolymere | |
| BR0207378A (pt) | Tratamento de câncer | |
| DE60208177D1 (de) | Propylenpolymerzusammensetzung, formkörper und polyolefincopolymer | |
| DK2287204T3 (da) | Vandopløslige jern-kulhydrat-komplekser, fremstilling deraf og læge-midler, der indeholder disse | |
| PL374523A1 (pl) | Koniugaty pochodna kalicheamycyny-nośnik | |
| ATE377048T1 (de) | Abbaubare polyacetal-polymere | |
| SE0102315D0 (sv) | Compounds | |
| FR2811996B1 (fr) | Reticulation de polysaccharide(s), preparation d'hydrogel(s) ; polysaccharide(s) et hydrogel(s) obtenus,leurs utilisations | |
| IT1318488B1 (it) | Fluorovinileteri e polimeri da essi ottenibili. | |
| DE60219677D1 (de) | Wasserlösliche polymerkonjugate von retinoesäure | |
| ATE251891T1 (de) | Verflüssigbare pulverzusammensetzungen | |
| BR0112969A (pt) | Método de utilização de dicetopiperazinas e composições contendo-as | |
| ATE483738T1 (de) | Verfahren zur herstellung von copolymeren in gegenwart eines kettenübertragungsmittel | |
| UY27929A1 (es) | Composiciones farmaceuticas de farmacos semiordenados y polimeros | |
| ATE277640T1 (de) | Bioaktive und/oder gezielte dendrimere-konjugate enthaltend genetisches material | |
| DE69927688D1 (de) | Antivirales Mittel in Kombination mit Strahlentherapie zur Verwendung in der Behandlung von Krebs | |
| MXPA05008099A (es) | Productos n-aril-heteroaromaticos, composiciones que los contienen y su utilizacion. | |
| CY1105020T1 (el) | Υποκαταστατες διαζεπανες | |
| ATE443453T1 (de) | Tomatenprodukte | |
| AU2003233579A8 (en) | Synthesis of inorganic structures using templation and catalysis by self assembled repeat protein polymers |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |